Acadia waited for 5 years for this drug to be approved. Stock is up over 1000% since then. Any suitor interested (and we all know there are several) does not want to wait for preliminary Nuplazid sales estimates. What's better for you as a buyer, making a bid of $60 on a $31 stock or a bid of $60 on a $46 stock. I contend this will happen pretty soon.
The most serious being Allergen.
Wow, wonder why this comment gets so much attention? Buyout looks good I guess
I miss when he called for everyone to double down at $19.00. Yeah he wasssss waaaay off!
Look at the news feeds on ACAD'S symbol on Fidelity Web you zonker.
With or without buyout
Commercial.........as we speak.
And you have a MONSTER revenue generator.
$30 for the whole lot maybe.
$700 mill. That's upon commercial release and THEN INO gets royalty payments.
Guess what? INO is only worth about $750 mill tday. That's a double folks.